Enhancing the circulating half-life of interleukin-2 proteins

Details for Australian Patent Application No. 2004268055 (hide)

Owner Merck Patent GmbH

Inventors Gillies, Stephen; Way, Jeffrey; Lauder, Scott

Agent Davies Collison Cave

Pub. Number AU-B-2004268055

PCT Pub. Number WO2005/021592

Priority 60/498,618 28.08.03 US

Filing date 30 August 2004

Wipo publication date 10 March 2005

Acceptance publication date 3 March 2011

International Classifications

C07K 14/55 (2006.01) Peptides having more than 20 amino acids

Event Publications

13 April 2006 PCT application entered the National Phase

  PCT publication WO2005/021592 Priority application(s): WO2005/021592

3 March 2011 Application Accepted

  Published as AU-B-2004268055

7 July 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under reg. 22.2I(2). This application has been accepted or advertised accepted. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004268057-Process for the asymmetric hydrogenation of beta-amino ketones

2004268052-Aminopropanol derivatives